STAT+: Amgen’s Repatha linked to fewer heart attacks
Pithy intro text about the biopharma milieu. Novartis cites more tumor reports after Zolgensma Novartis has disclosed seven previously unreported cases of tumors in children who received Zolgensma, its gene therapy…
We haven't written up this one. STAT News has the full story — the link below goes straight to it.